Skip to main content

Table 1 Patient characteristics

From: Evaluation of chemosensitivity prediction using quantitative dose–response curve classification for highly advanced/relapsed gastric cancer

Characteristic Total (number = 43) Ascites (number = 22) Solid tumor (number = 21)
  Number % Number % Number %
Age, years
Median 59 53 68
Range 22 to 85 22 to 78 30 to 85
Sex
Male 30 69.8 15 68.2 15 71.4
Female 13 30.2 7 31.8 6 28.6
Stage a, b
II 2 4.7 0 0 2 9.5
IIIA 1 2.3 0 0 1 4.8
IIIB 5 11.6 1 4.5 4 19.0
IV 35 81.4 21 95.5 14 66.7
Histologyb
Intestinal 10 23.3 5 22.7 5 23.8
Diffuse 33 76.7 17 77.3 16 76.2
Stromab
Medullary type 5 11.6 0 0 5 23.8
Intermediate type 9 20.9 3 13.6 6 28.6
Scirrhous type 12 27.9 6 27.3 6 28.6
Unknown 17 39.5 13 59.1 4 19.0
Pre-therapy
Performed 30 69.8 16 72.7 14 66.7
Not performed 13 30.2 6 27.3 7 33.3
  1. aAJCC (American Joint Commettee on Cancer)/UICC (Union for International Cancer Control) classification.
  2. bStages, Histology, and Stroma for Ascites are of the primary lesions.